title: What should we clinicians do for healthy, asymptomatic, HBsAg-positive carriers?
authors.affiliation: Department of Medicine, Alaska Native Medical Center, Anchorage 99501.
authors.forename: B J
authors.initials: BJ
authors.lastname: McMahon
mesh_terms: D000328:Adult; D002353:Carrier State / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006801:Humans; D008297:Male; D011379:Prognosis
chemical_list: D006514:Hepatitis B Surface Antigens